Global Veterinary Regenerative Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 109

Published Date: 16 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Veterinary Regenerative Medicine market size was valued at USD 273.7 million in 2023 and is forecast to a readjusted size of USD 607.7 million by 2030 with a CAGR of 12.1% during review period.

Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types.

Regenerative medicine therapy has grown in popularity in both human and veterinary medicine for the treatment of a variety of disease conditions. In the rapidly developing field of veterinary regenerative medicine, cells, and tissues-such as live cells, serum, or bone-are utilized in animals with the hopes of restoring diseased or damaged tissues or organs. Recent studies have shown that it is effective in controlling a variety of orthopedic disorders in companion animals, including osteoarthritis and soft tissue injuries. Regenerative medicine is increasingly used as an alternative to surgical, medicinal, and rehabilitation therapy or as a multimodal approach to treating a condition or injury.

The Global Info Research report includes an overview of the development of the Veterinary Regenerative Medicine industry chain, the market status of Veterinary Hospitals/Clinics (Platelet-Rich Plasma (PRP), Stem Cell Therapy), Veterinary Research Institutes (Platelet-Rich Plasma (PRP), Stem Cell Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Veterinary Regenerative Medicine.

Regionally, the report analyzes the Veterinary Regenerative Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Veterinary Regenerative Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Veterinary Regenerative Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Veterinary Regenerative Medicine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Platelet-Rich Plasma (PRP), Stem Cell Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Veterinary Regenerative Medicine market.

Regional Analysis: The report involves examining the Veterinary Regenerative Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Veterinary Regenerative Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Veterinary Regenerative Medicine:
Company Analysis: Report covers individual Veterinary Regenerative Medicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Veterinary Regenerative Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Veterinary Hospitals/Clinics, Veterinary Research Institutes).

Technology Analysis: Report covers specific technologies relevant to Veterinary Regenerative Medicine. It assesses the current state, advancements, and potential future developments in Veterinary Regenerative Medicine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Veterinary Regenerative Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Veterinary Regenerative Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Others

Market segment by Application
Veterinary Hospitals/Clinics
Veterinary Research Institutes

Market segment by players, this report covers
ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Veterinary Regenerative Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Veterinary Regenerative Medicine, with revenue, gross margin and global market share of Veterinary Regenerative Medicine from 2019 to 2024.
Chapter 3, the Veterinary Regenerative Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Veterinary Regenerative Medicine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Regenerative Medicine.
Chapter 13, to describe Veterinary Regenerative Medicine research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Veterinary Regenerative Medicine
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Veterinary Regenerative Medicine by Type
        1.3.1 Overview: Global Veterinary Regenerative Medicine Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Veterinary Regenerative Medicine Consumption Value Market Share by Type in 2023
        1.3.3 Platelet-Rich Plasma (PRP)
        1.3.4 Stem Cell Therapy
        1.3.5 Others
    1.4 Global Veterinary Regenerative Medicine Market by Application
        1.4.1 Overview: Global Veterinary Regenerative Medicine Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Veterinary Hospitals/Clinics
        1.4.3 Veterinary Research Institutes
    1.5 Global Veterinary Regenerative Medicine Market Size & Forecast
    1.6 Global Veterinary Regenerative Medicine Market Size and Forecast by Region
        1.6.1 Global Veterinary Regenerative Medicine Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Veterinary Regenerative Medicine Market Size by Region, (2019-2030)
        1.6.3 North America Veterinary Regenerative Medicine Market Size and Prospect (2019-2030)
        1.6.4 Europe Veterinary Regenerative Medicine Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Veterinary Regenerative Medicine Market Size and Prospect (2019-2030)
        1.6.6 South America Veterinary Regenerative Medicine Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Veterinary Regenerative Medicine Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 ACell Inc. (Integra LifeSciences)
        2.1.1 ACell Inc. (Integra LifeSciences) Details
        2.1.2 ACell Inc. (Integra LifeSciences) Major Business
        2.1.3 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product and Solutions
        2.1.4 ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 ACell Inc. (Integra LifeSciences) Recent Developments and Future Plans
    2.2 Animal Cell Therapies, Inc.
        2.2.1 Animal Cell Therapies, Inc. Details
        2.2.2 Animal Cell Therapies, Inc. Major Business
        2.2.3 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product and Solutions
        2.2.4 Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Animal Cell Therapies, Inc. Recent Developments and Future Plans
    2.3 Ardent
        2.3.1 Ardent Details
        2.3.2 Ardent Major Business
        2.3.3 Ardent Veterinary Regenerative Medicine Product and Solutions
        2.3.4 Ardent Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Ardent Recent Developments and Future Plans
    2.4 Boehringer Ingelheim International GmbH
        2.4.1 Boehringer Ingelheim International GmbH Details
        2.4.2 Boehringer Ingelheim International GmbH Major Business
        2.4.3 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product and Solutions
        2.4.4 Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
    2.5 Cell Therapy Sciences
        2.5.1 Cell Therapy Sciences Details
        2.5.2 Cell Therapy Sciences Major Business
        2.5.3 Cell Therapy Sciences Veterinary Regenerative Medicine Product and Solutions
        2.5.4 Cell Therapy Sciences Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Cell Therapy Sciences Recent Developments and Future Plans
    2.6 Dechra
        2.6.1 Dechra Details
        2.6.2 Dechra Major Business
        2.6.3 Dechra Veterinary Regenerative Medicine Product and Solutions
        2.6.4 Dechra Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Dechra Recent Developments and Future Plans
    2.7 Enso Discoveries
        2.7.1 Enso Discoveries Details
        2.7.2 Enso Discoveries Major Business
        2.7.3 Enso Discoveries Veterinary Regenerative Medicine Product and Solutions
        2.7.4 Enso Discoveries Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Enso Discoveries Recent Developments and Future Plans
    2.8 South Paws Veterinary Surgical Specialists
        2.8.1 South Paws Veterinary Surgical Specialists Details
        2.8.2 South Paws Veterinary Surgical Specialists Major Business
        2.8.3 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product and Solutions
        2.8.4 South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 South Paws Veterinary Surgical Specialists Recent Developments and Future Plans
    2.9 Veterinary Specialty Center
        2.9.1 Veterinary Specialty Center Details
        2.9.2 Veterinary Specialty Center Major Business
        2.9.3 Veterinary Specialty Center Veterinary Regenerative Medicine Product and Solutions
        2.9.4 Veterinary Specialty Center Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Veterinary Specialty Center Recent Developments and Future Plans
    2.10 Vetbiologics
        2.10.1 Vetbiologics Details
        2.10.2 Vetbiologics Major Business
        2.10.3 Vetbiologics Veterinary Regenerative Medicine Product and Solutions
        2.10.4 Vetbiologics Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Vetbiologics Recent Developments and Future Plans
    2.11 Vetherapy
        2.11.1 Vetherapy Details
        2.11.2 Vetherapy Major Business
        2.11.3 Vetherapy Veterinary Regenerative Medicine Product and Solutions
        2.11.4 Vetherapy Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Vetherapy Recent Developments and Future Plans
    2.12 VetStem, Inc.
        2.12.1 VetStem, Inc. Details
        2.12.2 VetStem, Inc. Major Business
        2.12.3 VetStem, Inc. Veterinary Regenerative Medicine Product and Solutions
        2.12.4 VetStem, Inc. Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 VetStem, Inc. Recent Developments and Future Plans
    2.13 Zoetis
        2.13.1 Zoetis Details
        2.13.2 Zoetis Major Business
        2.13.3 Zoetis Veterinary Regenerative Medicine Product and Solutions
        2.13.4 Zoetis Veterinary Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Zoetis Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Veterinary Regenerative Medicine Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Veterinary Regenerative Medicine by Company Revenue
        3.2.2 Top 3 Veterinary Regenerative Medicine Players Market Share in 2023
        3.2.3 Top 6 Veterinary Regenerative Medicine Players Market Share in 2023
    3.3 Veterinary Regenerative Medicine Market: Overall Company Footprint Analysis
        3.3.1 Veterinary Regenerative Medicine Market: Region Footprint
        3.3.2 Veterinary Regenerative Medicine Market: Company Product Type Footprint
        3.3.3 Veterinary Regenerative Medicine Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Veterinary Regenerative Medicine Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Veterinary Regenerative Medicine Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Veterinary Regenerative Medicine Consumption Value Market Share by Application (2019-2024)
    5.2 Global Veterinary Regenerative Medicine Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Veterinary Regenerative Medicine Consumption Value by Type (2019-2030)
    6.2 North America Veterinary Regenerative Medicine Consumption Value by Application (2019-2030)
    6.3 North America Veterinary Regenerative Medicine Market Size by Country
        6.3.1 North America Veterinary Regenerative Medicine Consumption Value by Country (2019-2030)
        6.3.2 United States Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        6.3.3 Canada Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        6.3.4 Mexico Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Veterinary Regenerative Medicine Consumption Value by Type (2019-2030)
    7.2 Europe Veterinary Regenerative Medicine Consumption Value by Application (2019-2030)
    7.3 Europe Veterinary Regenerative Medicine Market Size by Country
        7.3.1 Europe Veterinary Regenerative Medicine Consumption Value by Country (2019-2030)
        7.3.2 Germany Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        7.3.3 France Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        7.3.5 Russia Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        7.3.6 Italy Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Veterinary Regenerative Medicine Market Size by Region
        8.3.1 Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Region (2019-2030)
        8.3.2 China Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        8.3.3 Japan Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        8.3.4 South Korea Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        8.3.5 India Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        8.3.7 Australia Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Veterinary Regenerative Medicine Consumption Value by Type (2019-2030)
    9.2 South America Veterinary Regenerative Medicine Consumption Value by Application (2019-2030)
    9.3 South America Veterinary Regenerative Medicine Market Size by Country
        9.3.1 South America Veterinary Regenerative Medicine Consumption Value by Country (2019-2030)
        9.3.2 Brazil Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        9.3.3 Argentina Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Veterinary Regenerative Medicine Market Size by Country
        10.3.1 Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Country (2019-2030)
        10.3.2 Turkey Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)
        10.3.4 UAE Veterinary Regenerative Medicine Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Veterinary Regenerative Medicine Market Drivers
    11.2 Veterinary Regenerative Medicine Market Restraints
    11.3 Veterinary Regenerative Medicine Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Veterinary Regenerative Medicine Industry Chain
    12.2 Veterinary Regenerative Medicine Upstream Analysis
    12.3 Veterinary Regenerative Medicine Midstream Analysis
    12.4 Veterinary Regenerative Medicine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Veterinary Regenerative Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Veterinary Regenerative Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Veterinary Regenerative Medicine Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Veterinary Regenerative Medicine Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. ACell Inc. (Integra LifeSciences) Company Information, Head Office, and Major Competitors
    Table 6. ACell Inc. (Integra LifeSciences) Major Business
    Table 7. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Product and Solutions
    Table 8. ACell Inc. (Integra LifeSciences) Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. ACell Inc. (Integra LifeSciences) Recent Developments and Future Plans
    Table 10. Animal Cell Therapies, Inc. Company Information, Head Office, and Major Competitors
    Table 11. Animal Cell Therapies, Inc. Major Business
    Table 12. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Product and Solutions
    Table 13. Animal Cell Therapies, Inc. Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Animal Cell Therapies, Inc. Recent Developments and Future Plans
    Table 15. Ardent Company Information, Head Office, and Major Competitors
    Table 16. Ardent Major Business
    Table 17. Ardent Veterinary Regenerative Medicine Product and Solutions
    Table 18. Ardent Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Ardent Recent Developments and Future Plans
    Table 20. Boehringer Ingelheim International GmbH Company Information, Head Office, and Major Competitors
    Table 21. Boehringer Ingelheim International GmbH Major Business
    Table 22. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Product and Solutions
    Table 23. Boehringer Ingelheim International GmbH Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Boehringer Ingelheim International GmbH Recent Developments and Future Plans
    Table 25. Cell Therapy Sciences Company Information, Head Office, and Major Competitors
    Table 26. Cell Therapy Sciences Major Business
    Table 27. Cell Therapy Sciences Veterinary Regenerative Medicine Product and Solutions
    Table 28. Cell Therapy Sciences Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Cell Therapy Sciences Recent Developments and Future Plans
    Table 30. Dechra Company Information, Head Office, and Major Competitors
    Table 31. Dechra Major Business
    Table 32. Dechra Veterinary Regenerative Medicine Product and Solutions
    Table 33. Dechra Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Dechra Recent Developments and Future Plans
    Table 35. Enso Discoveries Company Information, Head Office, and Major Competitors
    Table 36. Enso Discoveries Major Business
    Table 37. Enso Discoveries Veterinary Regenerative Medicine Product and Solutions
    Table 38. Enso Discoveries Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Enso Discoveries Recent Developments and Future Plans
    Table 40. South Paws Veterinary Surgical Specialists Company Information, Head Office, and Major Competitors
    Table 41. South Paws Veterinary Surgical Specialists Major Business
    Table 42. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Product and Solutions
    Table 43. South Paws Veterinary Surgical Specialists Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. South Paws Veterinary Surgical Specialists Recent Developments and Future Plans
    Table 45. Veterinary Specialty Center Company Information, Head Office, and Major Competitors
    Table 46. Veterinary Specialty Center Major Business
    Table 47. Veterinary Specialty Center Veterinary Regenerative Medicine Product and Solutions
    Table 48. Veterinary Specialty Center Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Veterinary Specialty Center Recent Developments and Future Plans
    Table 50. Vetbiologics Company Information, Head Office, and Major Competitors
    Table 51. Vetbiologics Major Business
    Table 52. Vetbiologics Veterinary Regenerative Medicine Product and Solutions
    Table 53. Vetbiologics Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Vetbiologics Recent Developments and Future Plans
    Table 55. Vetherapy Company Information, Head Office, and Major Competitors
    Table 56. Vetherapy Major Business
    Table 57. Vetherapy Veterinary Regenerative Medicine Product and Solutions
    Table 58. Vetherapy Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Vetherapy Recent Developments and Future Plans
    Table 60. VetStem, Inc. Company Information, Head Office, and Major Competitors
    Table 61. VetStem, Inc. Major Business
    Table 62. VetStem, Inc. Veterinary Regenerative Medicine Product and Solutions
    Table 63. VetStem, Inc. Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. VetStem, Inc. Recent Developments and Future Plans
    Table 65. Zoetis Company Information, Head Office, and Major Competitors
    Table 66. Zoetis Major Business
    Table 67. Zoetis Veterinary Regenerative Medicine Product and Solutions
    Table 68. Zoetis Veterinary Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Zoetis Recent Developments and Future Plans
    Table 70. Global Veterinary Regenerative Medicine Revenue (USD Million) by Players (2019-2024)
    Table 71. Global Veterinary Regenerative Medicine Revenue Share by Players (2019-2024)
    Table 72. Breakdown of Veterinary Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Veterinary Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 74. Head Office of Key Veterinary Regenerative Medicine Players
    Table 75. Veterinary Regenerative Medicine Market: Company Product Type Footprint
    Table 76. Veterinary Regenerative Medicine Market: Company Product Application Footprint
    Table 77. Veterinary Regenerative Medicine New Market Entrants and Barriers to Market Entry
    Table 78. Veterinary Regenerative Medicine Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Veterinary Regenerative Medicine Consumption Value (USD Million) by Type (2019-2024)
    Table 80. Global Veterinary Regenerative Medicine Consumption Value Share by Type (2019-2024)
    Table 81. Global Veterinary Regenerative Medicine Consumption Value Forecast by Type (2025-2030)
    Table 82. Global Veterinary Regenerative Medicine Consumption Value by Application (2019-2024)
    Table 83. Global Veterinary Regenerative Medicine Consumption Value Forecast by Application (2025-2030)
    Table 84. North America Veterinary Regenerative Medicine Consumption Value by Type (2019-2024) & (USD Million)
    Table 85. North America Veterinary Regenerative Medicine Consumption Value by Type (2025-2030) & (USD Million)
    Table 86. North America Veterinary Regenerative Medicine Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. North America Veterinary Regenerative Medicine Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. North America Veterinary Regenerative Medicine Consumption Value by Country (2019-2024) & (USD Million)
    Table 89. North America Veterinary Regenerative Medicine Consumption Value by Country (2025-2030) & (USD Million)
    Table 90. Europe Veterinary Regenerative Medicine Consumption Value by Type (2019-2024) & (USD Million)
    Table 91. Europe Veterinary Regenerative Medicine Consumption Value by Type (2025-2030) & (USD Million)
    Table 92. Europe Veterinary Regenerative Medicine Consumption Value by Application (2019-2024) & (USD Million)
    Table 93. Europe Veterinary Regenerative Medicine Consumption Value by Application (2025-2030) & (USD Million)
    Table 94. Europe Veterinary Regenerative Medicine Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Veterinary Regenerative Medicine Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Type (2019-2024) & (USD Million)
    Table 97. Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Type (2025-2030) & (USD Million)
    Table 98. Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Application (2019-2024) & (USD Million)
    Table 99. Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Application (2025-2030) & (USD Million)
    Table 100. Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Region (2019-2024) & (USD Million)
    Table 101. Asia-Pacific Veterinary Regenerative Medicine Consumption Value by Region (2025-2030) & (USD Million)
    Table 102. South America Veterinary Regenerative Medicine Consumption Value by Type (2019-2024) & (USD Million)
    Table 103. South America Veterinary Regenerative Medicine Consumption Value by Type (2025-2030) & (USD Million)
    Table 104. South America Veterinary Regenerative Medicine Consumption Value by Application (2019-2024) & (USD Million)
    Table 105. South America Veterinary Regenerative Medicine Consumption Value by Application (2025-2030) & (USD Million)
    Table 106. South America Veterinary Regenerative Medicine Consumption Value by Country (2019-2024) & (USD Million)
    Table 107. South America Veterinary Regenerative Medicine Consumption Value by Country (2025-2030) & (USD Million)
    Table 108. Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Type (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Type (2025-2030) & (USD Million)
    Table 110. Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Application (2019-2024) & (USD Million)
    Table 111. Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Application (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Country (2019-2024) & (USD Million)
    Table 113. Middle East & Africa Veterinary Regenerative Medicine Consumption Value by Country (2025-2030) & (USD Million)
    Table 114. Veterinary Regenerative Medicine Raw Material
    Table 115. Key Suppliers of Veterinary Regenerative Medicine Raw Materials
List of Figures
    Figure 1. Veterinary Regenerative Medicine Picture
    Figure 2. Global Veterinary Regenerative Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Veterinary Regenerative Medicine Consumption Value Market Share by Type in 2023
    Figure 4. Platelet-Rich Plasma (PRP)
    Figure 5. Stem Cell Therapy
    Figure 6. Others
    Figure 7. Global Veterinary Regenerative Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Veterinary Regenerative Medicine Consumption Value Market Share by Application in 2023
    Figure 9. Veterinary Hospitals/Clinics Picture
    Figure 10. Veterinary Research Institutes Picture
    Figure 11. Global Veterinary Regenerative Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Veterinary Regenerative Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Veterinary Regenerative Medicine Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Veterinary Regenerative Medicine Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Veterinary Regenerative Medicine Consumption Value Market Share by Region in 2023
    Figure 16. North America Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Veterinary Regenerative Medicine Revenue Share by Players in 2023
    Figure 22. Veterinary Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Veterinary Regenerative Medicine Market Share in 2023
    Figure 24. Global Top 6 Players Veterinary Regenerative Medicine Market Share in 2023
    Figure 25. Global Veterinary Regenerative Medicine Consumption Value Share by Type (2019-2024)
    Figure 26. Global Veterinary Regenerative Medicine Market Share Forecast by Type (2025-2030)
    Figure 27. Global Veterinary Regenerative Medicine Consumption Value Share by Application (2019-2024)
    Figure 28. Global Veterinary Regenerative Medicine Market Share Forecast by Application (2025-2030)
    Figure 29. North America Veterinary Regenerative Medicine Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Veterinary Regenerative Medicine Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Veterinary Regenerative Medicine Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Veterinary Regenerative Medicine Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Veterinary Regenerative Medicine Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Veterinary Regenerative Medicine Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Veterinary Regenerative Medicine Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Veterinary Regenerative Medicine Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Veterinary Regenerative Medicine Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Veterinary Regenerative Medicine Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Veterinary Regenerative Medicine Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Veterinary Regenerative Medicine Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Veterinary Regenerative Medicine Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Veterinary Regenerative Medicine Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Veterinary Regenerative Medicine Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Veterinary Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 63. Veterinary Regenerative Medicine Market Drivers
    Figure 64. Veterinary Regenerative Medicine Market Restraints
    Figure 65. Veterinary Regenerative Medicine Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Veterinary Regenerative Medicine in 2023
    Figure 68. Manufacturing Process Analysis of Veterinary Regenerative Medicine
    Figure 69. Veterinary Regenerative Medicine Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

ACell Inc. (Integra LifeSciences)
Animal Cell Therapies, Inc.
Ardent
Boehringer Ingelheim International GmbH
Cell Therapy Sciences
Dechra
Enso Discoveries
South Paws Veterinary Surgical Specialists
Veterinary Specialty Center
Vetbiologics
Vetherapy
VetStem, Inc.
Zoetis

Related Reports

Global Veterinary Regenerative Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Veterinary Regenerative Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Jun 2023

date Medical Care

According to our (Global Info Research) latest study, the global Veterinary Regenerative Medicine market size was valued at USD 273.7 million in 2022 and is forecast to a readjusted size of USD 607.7 million by 2029 with a CAGR of 12.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Veterinary Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Global Veterinary Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

date 10 Jun 2023

date Medical Care

The global Veterinary Regenerative Medicine market size is expected to reach $ 607.7 million by 2029, rising at a market growth of 12.1% CAGR during the forecast period (2023-2029).

Global Veterinary Regenerative Medicine Supply, Demand and Key Producers, 2024-2030

Global Veterinary Regenerative Medicine Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Medical Care

The global Veterinary Regenerative Medicine market size is expected to reach $ 607.7 million by 2030, rising at a market growth of 12.1% CAGR during the forecast period (2024-2030).

Product Tags

Veterinary Regenerative Medicine

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>